RELX (RELX) releases 2025 Annual Report, Form 20-F and NL report
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
RELX PLC has published its 2025 Annual Report and its 2025 Annual Report on Form 20-F, making both documents available on its website and through relevant regulatory platforms in the UK, US and Netherlands.
The 2025 Form 20-F has been filed with the US Securities and Exchange Commission, and the 2025 NL Annual Report has been prepared under European Single Electronic Format rules for submission to the Dutch Authority for the Financial Markets. The company reports that total voting rights in its issued share capital, excluding treasury shares, are 1,812,039,253.
Positive
- None.
Negative
- None.
FAQ
What did RELX (RELX) announce in this Form 6-K filing?
RELX announced publication of its 2025 Annual Report, its 2025 Form 20-F, and its 2025 NL Annual Report. These reports are now available on the company’s website and via UK, US and Dutch regulatory platforms for investors and other stakeholders.
Where can investors access RELX’s 2025 Form 20-F and audited financial statements?
The 2025 Form 20-F is filed with the US SEC and available at www.sec.gov, and on RELX’s website. Holders of RELX securities can also request hard copies, including audited financial statements, free of charge from RELX PLC’s Company Secretariat.
How is RELX complying with European reporting requirements in 2025?
RELX’s 2025 NL Annual Report has been prepared under European Single Electronic Format rules applicable due to its Euronext Amsterdam listing. The report will be submitted to the Dutch Authority for the Financial Markets, which publishes it in its public register for investors.
What forward-looking statement warnings does RELX highlight in connection with its 2025 reports?
RELX notes that its 2025 Annual Report and 2025 Form 20-F contain forward-looking statements subject to risks and uncertainties. It lists factors such as regulation, economic conditions, cybersecurity, acquisitions, tax changes and credit ratings that could cause actual results to differ materially.